Danaher Corporation (DHR) vs Vertex Pharmaceuticals Incorporated (VRTX)
VRTX leads on 12 of 16 compared metrics.
A side-by-side comparison of Danaher Corporation and Vertex Pharmaceuticals Incorporated across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of June 13, 2026. The ● marks the stronger figure on each row (cheaper multiple, higher margin/return).
DHR
Danaher Corporation
$180.10Healthcare
VRTX
Vertex Pharmaceuticals Incorporated
$444.93Healthcare
Total return — DHR vs VRTX
growth of $100 · last 30yDHR +5181.5%VRTX +2389.1%DHR compounded faster
DHR VRTX
DHR vs VRTX: by the numbers
- •DHR is the larger company ($127.47B vs $112.92B market cap).
- •VRTX trades at the lower earnings multiple (26.39 vs 34.84 P/E).
- •VRTX converts more revenue to profit (35.40% vs 14.89% net margin).
- •VRTX grew revenue faster over the past five years (13.82% vs 2.05% CAGR).
- •DHR pays a dividend (0.76% yield) while VRTX does not currently pay one.
Which is better, DHR or VRTX?
Metric tally: DHR 4 · VRTX 12It depends on what you're optimizing for:
ValueVRTX(lower P/E)
GrowthVRTX(faster 5Y revenue CAGR)
QualityVRTX(higher ROIC)
Valuation
| Metric | DHR | VRTX |
|---|---|---|
| P/E ratio | 34.84 | 26.39● |
| Forward P/E | 19.73● | 20.58 |
| P/S ratio | 5.17● | 9.31 |
| P/B ratio | 2.42● | 5.89 |
| PEG ratio | 87.09 | 3.23● |
| EV / EBITDA | 21.20 | 20.72● |
| FCF yield | 4.13%● | 3.25% |
Profitability
| Metric | DHR | VRTX |
|---|---|---|
| Gross margin | 60.68% | 86.28%● |
| Operating margin | 20.95% | 38.97%● |
| Net margin | 14.89% | 35.40%● |
| ROE | 6.97% | 22.41%● |
| ROIC | 5.72% | 18.12%● |
Dividends
| Metric | DHR | VRTX |
|---|---|---|
| Dividend yield | 0.76% | — |
| Payout ratio | 26.82% | — |
Growth (annualized)
| Metric | DHR | VRTX |
|---|---|---|
| Revenue CAGR (5Y) | 2.05% | 13.82%● |
| EPS CAGR (5Y) | 0.40% | 8.17%● |
| FCF CAGR (5Y) | -0.45% | 4.01%● |
| Total return CAGR (5Y) | -3.38% | 18.17%● |
Frequently asked
- Which is better, DHR or VRTX?
- It depends on your goal. value: VRTX (lower P/E); growth: VRTX (faster 5Y revenue CAGR); quality: VRTX (higher ROIC). Across all compared metrics, VRTX leads 12 to 4.
- Is DHR or VRTX cheaper?
- On trailing earnings, VRTX is cheaper: DHR trades at a 34.84 P/E and VRTX at 26.39.
- Which has grown faster, DHR or VRTX?
- Over the past five years, VRTX grew revenue faster — DHR at a 2.05% CAGR versus VRTX at 13.82%.
- Does DHR or VRTX pay a bigger dividend?
- DHR pays a dividend (0.76% yield) while VRTX does not currently pay one.
- Is DHR or VRTX more profitable?
- VRTX runs the higher net margin — DHR at 14.89% versus VRTX at 35.40%.
- Which has been the better investment, DHR or VRTX?
- Over the past 10-year, VRTX delivered the higher annualized total return — DHR at 10.98% versus VRTX at 17.13%. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Danaher P/E ratioVertex Pharmaceuticals P/E ratioDanaher dividend yieldVertex Pharmaceuticals dividend yieldDanaher ROEVertex Pharmaceuticals ROEDanaher operating marginVertex Pharmaceuticals operating marginDanaher revenue growthVertex Pharmaceuticals revenue growthDanaher free cash flowVertex Pharmaceuticals free cash flow
Danaher & Vertex Pharmaceuticals appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified June 13, 2026.